‘Twist Your View On Otitis Treatment’: Virbac Invites Delegates To Complimentary CPD Webinar

6 months ago
953 views

Posted
22nd August, 2024 10h55

Author
Virbac Animal Health

To celebrate the much-heralded launch of Cortotic, a corticosteroid-only treatment for the clinical signs associated with canine otitis externa¹, without an antimicrobial², Virbac is pleased to invite veterinary professionals to ‘Otitis Externa: Understanding Ear Disease’, a complimentary webinar to take place at 7:30pm on Tuesday 10^th September 2024.

The webinar will be presented by RCVS Recognised Specialist in Veterinary Dermatology, Dr Stephen Shaw BVetMed CertSAD DVD PhD PgCAP FHEA MRCVS. 

The World Health Organization has declared that antimicrobial resistance is one of the top global public health threats of our time³.  Join the webinar to explore how  Cortotic offers clinicians the ability to reduce antimicrobial usage when treating otitis externa in dogs, whilst offering the same efficacy as a fixed-combination product⁴.

REGISTER NOW to join the webinar live or to be able to watch it on demand at https://bit.ly/CortoticWebinar

References 1. For the treatment of clinical signs associated with acute erythroceruminous otitis externa (Cortotic Summary of Product Characteristics) 2. A secondary reduction of bacterial and yeast overgrowth was demonstrated and a concomitant treatment with an antimicrobial was unnecessary (Cortotic Summary of Product Characteristics) 3. World Health Organization. Antimicrobial resistance. 2023. https://www.who.int/newsroom/factsheets/detail/antimicrobial-resistance (accessed 9th April 2024). 4. Rigaut D, Briantais P, Jasmin P, Bidaud A. Efficacy and safety of a hydrocortisone aceponate containing ear spray solution in dogs with erythemato-ceruminous otitis externa: A randomised, multicentric, single-blinded, controlled trial. Vet Dermatol. 2024 Apr;35(2):197-206.

More from Virbac Animal Health

• Unlock Expert Knowledge on Cushing’s Syndrome in Dogs With Complimentary Webinar
• Virbac recognised as one of the UK’s Best Workplaces™
• Virbac Launches Trilotab®, the First Chewable, Flavoured & Divisible Trilostane Tablet to Treat Cushing’s Syndrome in Dogs
• Virbac Announce the Arrival of Syvazul BTV3, a Bluetongue Vaccine for Sheep & Cattle, Into the UK
• Will Balhatchet crowned Young Dairy Vet of the Year 2024